| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/08/2009 | CN100475849C Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/08/2009 | CN100475848C Anti-TRAIL-R antibodies |
| 04/08/2009 | CN100475844C Corticotropin releasing factor receptor 2 agonists |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475842C Molecular structure of RHD negative genes locus |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514539 Epitope directed selection of antibodies to murine tissue factor |
| 04/07/2009 | US7514538 Compositions and methods for the diagnosis and treatment of tumor |
| 04/07/2009 | US7514537 Chimeric immunoreceptor useful in treating human gliomas |
| 04/07/2009 | US7514534 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 04/07/2009 | US7514529 Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines |
| 04/07/2009 | US7514399 Use in tissue bonding and protein cross-linking and use in tissue and arterial repair, preservation of expanded internal luminal diameters, and local delivery of drugs, skin care materials, sunscreens, and cosmetics |
| 04/07/2009 | US7514240 a crystal complex of an epidermal growth factor (EGF) and an epidermal growth factor receptor (EGFR), used for screening and for designing the substance that regulate EGFR activity |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514231 Anti-aurora-A monoclonal antibody, method for obtaining same and uses thereof for diagnosing and treating cancers |
| 04/07/2009 | US7514227 contacting an antibodies or fragments which binds to human mitochondrial adenylate kinase isozymes with biological sample from a subject and normal control subject, then detecting the immune complex formed as detection markers for diagnosing myocardial infarction |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514223 Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule |
| 04/07/2009 | US7514221 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/07/2009 | US7514208 Methods for identifying modulators of cyclic nucleotide-gated cation channels |
| 04/07/2009 | US7514207 Administering compound (antibodies, ATP analogs) that inhibits p-21 activated kinase (PAK) activity and/or merlin phosphorylation; drug screening; neurofibromatosis |
| 04/07/2009 | US7514079 prevention and treatment of cancer as well as immune system diseases and disorders including pre-eclampsia, hypertension, inflammation, asthma, gastrointestinal disorders, anxiety, depression, addiction, or pain; host cell; kits; expression vector |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | US7514077 administering an antibody that binds Interleukins, to neurons, for the treatment of inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues; antiinflammatory agents; analgesics |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | CA2389943C Human antibodies that bind human tnf.alpha. |
| 04/07/2009 | CA2375448C Method for detecting syphilis using synthetic antigens |
| 04/07/2009 | CA2269060C Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/07/2009 | CA2206343C Reagents and processes for targeting mutant epidermal growth factor receptors |
| 04/07/2009 | CA2175332C Haemophilus transferrin receptor genes |
| 04/07/2009 | CA2127262C Somatostatin receptors |
| 04/07/2009 | CA2102115C In vitro methods for determining in vivo thrombotic events |
| 04/07/2009 | CA2100472C Inherited and somatic mutations of apc gene in colerectal cancer of humans |
| 04/02/2009 | WO2009043057A2 Cell rolling separation |
| 04/02/2009 | WO2009043051A2 Cd23 binding molecules and methods of use thereof |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009042589A1 Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| 04/02/2009 | WO2009042542A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | WO2009042504A1 Resistin antagonists and their use |
| 04/02/2009 | WO2009041902A1 Prion protein derived cell penetrating peptides and their uses |
| 04/02/2009 | WO2009041734A1 Agonistic antibody against human thrombopoietin receptor |
| 04/02/2009 | WO2009041643A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | WO2009041621A1 Anti-il-6 receptor antibody |
| 04/02/2009 | WO2009041613A1 Modified antibody constant region |
| 04/02/2009 | WO2009041501A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | WO2009041062A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 04/02/2009 | WO2009040562A1 Dual specificity antibody fusions |
| 04/02/2009 | WO2009040550A1 Materials and methods relating to modifying the binding of antibodies |
| 04/02/2009 | WO2009040508A2 Methods of detection and enrichment of prpsc by immunoprecipitation and elisa |
| 04/02/2009 | WO2009040451A1 Method of immunological analysis for detection of antibodies against human gstt1 (anti-hgstt1) |
| 04/02/2009 | WO2009040426A1 Immunoliposomes for treatment of cancer |
| 04/02/2009 | WO2009040268A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 04/02/2009 | WO2009040134A1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 04/02/2009 | WO2009039639A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
| 04/02/2009 | WO2009039630A1 Optimized nucleic acid sequences for the expression of vb4-845 |
| 04/02/2009 | WO2009019458A3 Erythropoietin fusion proteins |
| 04/02/2009 | WO2009018226A3 Pharmaceutical combinations comprising a tyrosine kinase inhibitor and an antibody against integrin alpha 1 beta 5 (cd49e) |
| 04/02/2009 | WO2009011941A3 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 04/02/2009 | WO2009005809A3 Compositions and methods for treating and diagnosing cancer |
| 04/02/2009 | WO2009004494A3 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications |
| 04/02/2009 | WO2008151088A3 Immunoglobulin constant region fc receptor binding agents |
| 04/02/2009 | WO2008150485A3 Erbb2 binding proteins and use thereof |
| 04/02/2009 | WO2008149149A3 Polypeptides, antibody variable domains and antagonists |
| 04/02/2009 | WO2008149148A3 Polypeptides, antibody variable domains and antagonists |
| 04/02/2009 | WO2008149144A3 Polypeptides, antibody variable domains and antagonists |
| 04/02/2009 | WO2008149143A3 Methods for selecting protease resistant polypeptides |
| 04/02/2009 | WO2008140653A3 Humaneered anti-factor b antibody |
| 04/02/2009 | WO2008112004A3 ANTIBODIES DIRECTED TO αVβ6 AND USES THEREOF |
| 04/02/2009 | WO2008051448A3 Methods and compositions for efficient removal of protein a from binding molecule preparations |
| 04/02/2009 | WO2007115150A3 Binding partners with immunoglobulin domains modified to have extended half-life |
| 04/02/2009 | WO2007090094A3 Thermally-targeted delivery of medicaments, including doxorubicin |
| 04/02/2009 | WO2007011907A3 Alpha-synuclein antibodies and methods related thereto |
| 04/02/2009 | WO2006063133A3 Biomarker for inflammatory bowel disease |
| 04/02/2009 | WO2006004910A3 Improved bispecific antibodies |
| 04/02/2009 | WO2005044974A3 Cell death-related nucleases and their uses |
| 04/02/2009 | WO2004080394A3 Stat3 antagonists and their use as vaccines against cancer |
| 04/02/2009 | WO2003087125A3 A novel g protein-coupled purinergic receptor, gave 17 |
| 04/02/2009 | WO2003012026A8 Apparatus and method for determining the onset and presence of sepsis conditions |
| 04/02/2009 | US20090088561 Enhancing the circulating half-life of antibody-based fusion proteins |
| 04/02/2009 | US20090088558 Tumor necrosis factor specific antibody hybrid for use in treatment and prevention of autoimmune, rheumatoid arthritic, graft rejection and graft-versus-host disorder |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088385 immunoglobulins; fibronectins; drug screening |
| 04/02/2009 | US20090088370 Method for Improved Isolation of Recombinantly Produced Proteins |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087876 Methods and compositions useful for modulating drug-induced impairment |
| 04/02/2009 | US20090087865 Monoclonal Antibodies to Tacrolimus and Immunoassays Methods for Tacrolimus |
| 04/02/2009 | US20090087863 Method For Detecting Polypeptide Toxic to Diabrotica Insects |
| 04/02/2009 | US20090087860 Highly sensitive system and methods for analysis of prostate specific antigen (psa) |
| 04/02/2009 | US20090087842 used to find a novel protein linked to the cytomatrix and considered to play an important role in synaptogenesis; detection and quantification of CAST |
| 04/02/2009 | US20090087836 Cytokines; fab fragments; fv fragments; monoclonal antibodies |
| 04/02/2009 | US20090087478 Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them |
| 04/02/2009 | US20090087474 Therapeutic use of growth factors,nsg29 and nsg31 |
| 04/02/2009 | US20090087458 Activatable recombinant neurotoxins |
| 04/02/2009 | US20090087447 Novel HCV non-structural polypeptide |
| 04/02/2009 | US20090087442 antibody designated RM4 and selectively binds to an antigen designated AgRM4; for treament of neoplasia; competitive binding; kits |
| 04/02/2009 | US20090087438 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 04/02/2009 | US20090087435 Isolated Chimeric Proteins Of Modified Lumazine Synthase |
| 04/02/2009 | US20090087432 TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES |
| 04/02/2009 | US20090087430 Selective inhibition of toll-like receptor-2 |